Leman Medical Technologies SA was established in 2009 and has the CE Mark for the FloWatch Pulmonary Artery Band. The implantable device is currently used in infants with curtain complex congenital heart defects suitable for conventional pulmonary artery banding.
The FloWatch-PAB uses patented wireless technology to send instructions, receive feedback and adjust the implanted device, therefore the implanted device does not contain a battery, all power coming from the signal.
We are actively investigating other indications for the FloWatch-PAB, and the development of the technology for current and other medical uses. This will be with in-house resources and in partnership with others.
LemanMedical will establish it’s own clean production facility (ISO-7 Class-10,000) during the first half of 2012, to-date production has been subcontracted. We will also have facilities for development and testing.
The FW-PAB is approved in many European and Middle-East countries and LemanMedical is active in expanding further.
The FloWatch-PAB has several proven clinical and financial advantages including:
- Accurate and repeatable wireless adjustment
- Ease of implantation and removal
- Elimination of need for reconstructive surgery on band removal
- Significant reduction in post-operative mechanical ventilation and ICU & hospital stay
- Improved mortality rates
Website: www.lemanmedical.com